In the latest trading session, Signet (SIG) closed at $64.22, marking a +1.94% move from the previous day.

Dollar Tree (DLTR) closed at $89.97 in the latest trading session, marking a +1.18% move from the prior day.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=149858&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Despite Oxford Lane Capital Corporation's 24% dividend yield, I recommend avoiding it due to its poor track record and inability to cover its dividend. Net investment income per share is declining sharply, failing to cover the dividend and suggesting a high risk of future dividend cuts. Net asset value per share is dropping rapidly, and the stock trades at a premium to NAV nevertheless.

In the most recent trading session, American Eagle Outfitters (AEO) closed at $10.85, indicating a +1.97% shift from the previous trading day.

In the closing of the recent trading day, Morgan Stanley (MS) stood at $126.16, denoting a +0.68% change from the preceding trading day.

In the closing of the recent trading day, Interactive Brokers Group, Inc. (IBKR) stood at $206.72, denoting a +0.71% change from the preceding trading day.

In the most recent trading session, Kinder Morgan (KMI) closed at $27.34, indicating a -0.47% shift from the previous trading day.

In the most recent trading session, AZZ (AZZ) closed at $89.61, indicating a -0.76% shift from the previous trading day.

Intel Corporation is our swing trade safe haven: buy under $20, sell above $23, and hold for the 18A node catalyst into 2026. 18A node is a game-changer with GAA and backside power; it'll enable share gain on PC Client from AMD and put IFS on the map against TSMC. Valuation is attractive, with INTC stock trading at a significant discount to peers, and expectations are getting revised down making for an easier beat.

MONETT, Mo. , May 22, 2025 /PRNewswire/ -- Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today that it will be participating in the following upcoming conference: Greg Adelson, President & CEO, will present at Bernstein's 41st Annual Strategic Decisions Conference on May 28 th.

Carnival (CCL) closed at $22.41 in the latest trading session, marking a +1.66% move from the prior day.

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.51, denoting a -0.44% change from the preceding trading day.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / WHY: New York, N.Y., May 22, 2025.

The lawsuit, filed in the waning days of the Biden administration, alleged that PepsiCo was giving unfair price advantages to Walmart at the expense of other vendors and consumers.

Amazon.com, Inc. remains a Strong Buy as both e-commerce and cloud businesses deliver robust growth and margin expansion, despite recent stock gains. Generative AI is fueling AWS's accelerating revenue growth. Tariff headwinds may pressure near-term margins, but Amazon's dominant market position may make it a potential opportunity.

Although the revenue and EPS for Autodesk (ADSK) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Williams-Sonoma CEO Laura Alber told CNBC's Jim Cramer how the company is dealing with the effects of President Donald Trump's tariff hikes. "We've been busy," she said.

SAN DIEGO , May 22, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Compass Diversified Holdings (NYSE: CODI) publicly traded securities between May 1, 2024 and May 7, 2025, inclusive (the "Class Period"), have until July 8, 2025 to seek appointment as lead plaintiff of the Compass Diversified class action lawsuit. Captioned Augenbaum v.

NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=149855&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.